CAN
IRWD icon

Cetera Advisor Networks’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cetera Advisor Networks’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,213
Closed -$118K – 2657
2023
Q1 		$118K Sell
11,213
-145
-1% -$1.62K ﹤0.01% 2416
2022
Q4 		$141K Sell
11,358
-1,048
-8% -$11.9K ﹤0.01% 2338
2022
Q3 		$129K Buy
12,406
+1,385
+13% +$15.7K ﹤0.01% 1929
2022
Q2 		$127K Hold
11,021
– – ﹤0.01% 1926
2022
Q1 		$139K Buy
11,021
+893
+9% +$10.2K ﹤0.01% 1943
2021
Q4 		$118K Buy
+10,128
New +$124K ﹤0.01% 1951

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Cetera Advisor Networks's IRWD Position: Q2 2023 in Review

Cetera Advisor Networks sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 11,213 shares — an estimated $118K sold.

Cetera Advisor Networks first reported a position in IRWD in Q4 2021 and held it in 6 quarters. The position peaked at $141K in Q4 2022. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

  • Cetera Advisor Networks reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 11,213 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $118K.
  • Cetera Advisor Networks first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • Cetera Advisor Networks's Ironwood Pharmaceuticals position peaked at $141K in Q4 2022.
  • 252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on Cetera Advisor Networks's 13F filing for Q2 2023, filed 10 Aug 2023.